SciELO - Scientific Electronic Library Online

 
vol.95 número2Encuesta sobre colecho y lactancia materna en el Hospital Pediátrico - Centro Hospitalario Pereira Rossell (mayo - julio de 2021)Estudio descriptivo de pacientes con patología genética en una unidad de cuidados intensivos pediátricos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Links relacionados

Compartir


Archivos de Pediatría del Uruguay

versión impresa ISSN 0004-0584versión On-line ISSN 1688-1249

Resumen

HALTY, Margarita et al. SARS-CoV-2 infection in children under 15 years old with glomerulopathies in Uruguay: Clinical features, severity and evolution. Arch. Pediatr. Urug. [online]. 2024, vol.95, n.2, e215.  Epub 01-Dic-2024. ISSN 0004-0584.  https://doi.org/10.31134/ap.95.2.4.

Introduction:

infections can trigger a relapse in children with glomerulopathies (GP); the SARS-CoV-2 infection can have consequences for the cases of kidney disease comorbidity and for cases when patients receive immunosuppression (IS).

Objectives:

describe the SARS-CoV-2 infection severity in children with GP and assess the clinical course of the kidney disease.

Methodology:

we conducted a multicenter retrospective study in Uruguay (04/01/2020 - 06/30/2022) of children <15 years of age with a chronic GP, either on IS treatment or not, who presented a confirmed SARS-CoV-2 infection. We collected demographic, clinical, treatment, and patient evolution data.

Results:

we included 30 children, 18 boys, median age 9 years, 16 (53%) had an idiopathic nephrotic syndrome (INS), 28 (93%) had received some IS treatment, 23 (77%) were taking it at the time of the infection. Respiratory symptoms were mild in all patients; 6/30 (20%) were asymptomatic. The peak incidence (86.6%) occurred between January-May/2022; 7/30 (23.3%) had renal repercussions. Two patients (6,6%) were hospitalized with acute kidney failure: one (3,3%), with IgA nephropathy, presented with emergency hypertension and required hemodialysis, and the other one (3,3%), with IgM nephropathy, presented with nephrotic syndrome. Three children (10%) with INS relapsed (2 (6,6%) were asymptomatic) and 2 (6,6%) had no nephrotic proteinuria. All patients recovered their previous situation, 6/7 (85,7%) with steroids. Mophetil mycophenolate was temporarily reduced in 3/11 (27,2%) children and stopped in one (9%). None with lupus relapsed (n=4). None required oxygen, nor did they present multisystem inflammatory syndrome. No deaths were recorded.

Conclusions:

despite the low frequency of complications and good outcome, pediatric patients with COVID-19 should be monitored. Relapse can occur in asymptomatic infections.

Palabras clave : COVID-19; Glomerulonephritis; Immunosuppressants; Child; Adolescent.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )